Published in J Clin Eng on June 27, 1985
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med (1983) 8.26
The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med (1978) 7.17
A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group. Gastroenterology (1999) 4.13
Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem (1996) 3.95
A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors. Nature (1987) 3.00
Reorganizing an academic medical service: impact on cost, quality, patient satisfaction, and education. JAMA (1998) 2.53
An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults. Int J Obes Relat Metab Disord (2002) 2.16
Single amino acid substitutions in proteins of the armadillo gene family abolish their binding to alpha-catenin. J Biol Chem (1996) 2.07
Health service use among low-risk newborns after early discharge with and without nurse home visiting. J Am Board Fam Pract (1997) 1.97
Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med (1979) 1.87
Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med (1982) 1.83
Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell (1990) 1.80
Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase. Nature (1995) 1.79
A new immunodeficiency disorder in humans involving NK cells. Nature (1980) 1.78
Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000. JAMA (1991) 1.77
NIH conference. Recent advances in chronic granulomatous disease. Ann Intern Med (1983) 1.76
On the possibility of nonthermal biological effects of pulsed electromagnetic radiation. Biophys J (1970) 1.76
The association of protein with the polyadenylic acid of HeLa cell messenger RNA: evidence for a "transport" role of a 75,000 molecular weight polypeptide. J Mol Biol (1976) 1.58
Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells. J Clin Invest (1988) 1.56
Seven-day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther (2004) 1.53
Chicken soup rebound and relapse of pneumonia: report of a case. Chest (1975) 1.50
The effect of cyclosporine on the use of hospital resources for kidney transplantation. N Engl J Med (1989) 1.49
An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae. Am J Gastroenterol (2000) 1.44
Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes. J Clin Invest (1980) 1.43
Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function. J Exp Med (1980) 1.41
Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages. Cancer Genet Cytogenet (1998) 1.39
Abraham Lincoln and cardiac decompensation: a preliminary report. West J Med (1978) 1.38
The North American Conference of GI Fellows: medicine and the pharmaceutical industry at its best. Am J Gastroenterol (1994) 1.38
Mechanisms of human cell-mediated cytotoxicity. III. Dependence of natural killing on microtubule and microfilament integrity. J Immunol (1982) 1.37
The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res (1997) 1.37
Test-retest performance of a mailed version of the Medical Outcomes Study 36-Item Short-Form Health Survey among older adults. Med Care (1996) 1.36
Abraham Lincoln and aortic insufficiency. The declining health of the President. Calif Med (1972) 1.36
The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage. Mol Biochem Parasitol (1989) 1.27
Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2011) 1.26
DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. Cancer Res (1981) 1.25
Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis. Clin Exp Immunol (1978) 1.25
Evidence from UV transcription mapping in HeLa cells that heterogeneous nuclear RNA is the messenger RNA precursor. Proc Natl Acad Sci U S A (1977) 1.24
Diet therapy for rheumatoid arthritis. Arthritis Rheum (1983) 1.21
Work disability among adults with asthma. Chest (1993) 1.20
Human blood monocytes: characterization of negatively selected human monocytes and their suspension cell culture derivatives. Scand J Immunol (1981) 1.19
Insulin secretion and action in noninsulin-dependent diabetes mellitus. Is insulin resistance secondary to hypoinsulinemia? Am J Med (1983) 1.14
Congenital aneurysm of the left sinus of Valsalva. Report of a patient with 19-year survival without surgery. Chest (1986) 1.12
Relationship between glucose and fatty acid in myocardial infarction. Lancet (1966) 1.11
Increased risk of neisserial infections in systemic lupus erythematosus. Semin Arthritis Rheum (1990) 1.11
Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event. J Immunol (1982) 1.09
Age-related changes in the redox status of rat muscle cells and their role in enzyme-aging. Mech Ageing Dev (1985) 1.09
Immunoregulation in infection caused by Mycobacterium tuberculosis: the presence of suppressor monocytes and the alteration of subpopulations of T lymphocytes. J Infect Dis (1979) 1.08
Autologous and allogeneic intercellular interactions: modulation by adherent cells, irradiation, and in vitro and in vivo corticosteroids. J Immunol (1979) 1.04
Alteration of T-lymphocyte subpopulations in sarcoidosis. Clin Immunol Immunopathol (1978) 1.03
Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis. Arthritis Rheum (2009) 1.03
Mechanisms of human cell-mediated cytotoxicity. I. Modulation of natural killer cell activity by cyclic nucleotides. J Immunol (1982) 1.02
Association of Wegener's granulomatosis with HLA-B8. Clin Immunol Immunopathol (1979) 1.02
Scleroderma esophagus: a nonspecific entity. Ann Intern Med (1984) 1.02
Cross-sectional shape of collapsible tubes. Biophys J (1972) 1.02
Temporal evolution of the human coronary collateral circulation after myocardial infarction. J Am Coll Cardiol (1984) 1.01
A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. Am J Cardiol (1984) 0.97
Rheumatoid vasculitis: experience with 13 patients and review of the literature. Semin Arthritis Rheum (1985) 0.97
Rheumatoid-like arthritis presenting as idiopathic pulmonary hemosiderosis: a report and review of the literature. J Rheumatol (1986) 0.97
Psychiatric consultation in the nursing home. A survey of six states. Am J Geriatr Psychiatry (1998) 0.96
Are pressure ulcers preventable? A survey of experts. Adv Skin Wound Care (2002) 0.95
Public will not tolerate disruptive strikes. Hospitals (1975) 0.95
Use of an electronic stimulator for the treatment of dry mouth. J Oral Maxillofac Surg (1986) 0.94
Antigenic competition in the development of delayed hypersensitivity to the azobenzenearsonate group. Immunochemistry (1969) 0.94
Noncomplementarity in base sequences between the cohesive ends of coliphages 186 and lambda and the formation of interlocked rings between the two DNA's. Biopolymers (1967) 0.93
An unusual organism causing orbital cellulitis. Br J Ophthalmol (1979) 0.92
[N-(imidomethyl)-thiocyanates and -isothiocyanates (author's transl)]. Arch Pharm (Weinheim) (1974) 0.91
[Endoscopy of the salivary glands]. Ann Radiol (Paris) (1991) 0.91
Ectopic pregnancy in the United States: economic consequences and payment source trends. Obstet Gynecol (1993) 0.90
Mechanisms of corticosteroid action on lymphocyte subpopulations. V. Effects of in vivo hydrocortisone on the circulatory kinetics and function of naturally occuring and mitogen-induced suppressor cells in man. Cell Immunol (1979) 0.90
Conflicts of interest in fee for service and in HMO's. N Engl J Med (1978) 0.90
Life-threatening bacterial pneumonia in male homosexuals with laboratory features of the acquired immunodeficiency syndrome. Chest (1985) 0.89
Deficiency of active natural killer cells in the Chediak-Higashi syndrome. Localization of the defect using a single cell cytotoxicity assay. J Clin Invest (1982) 0.89
Assessment of the diet of patients with rheumatoid arthritis and osteoarthritis. J Am Diet Assoc (1983) 0.89
The effect of anti-diuretic hormone on the endolymphatic sac of the inner ear. Pflugers Arch (1998) 0.88
Colonic necrosis complicating postoperative pancreatitis. Ann Surg (1974) 0.88
[Reaction products of N-chloromethylisatin with proton active compounds. 19. N-(alpha-halogenalkyl) carbonic acid amide]. Arch Pharm (Weinheim) (1973) 0.88
Os intermetatarseum-one: case report and discussion. J Am Podiatry Assoc (1978) 0.87
Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Aliment Pharmacol Ther (2001) 0.87
Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. Am Heart J (1996) 0.86
Untreated (combined) intracardiac and valvular trauma with long asymptomatic survival. Am Heart J (1971) 0.86
An anterior transversalis fascia repair for adult inguinal hernias. Am J Surg (1978) 0.85
Serum angiotensin-converting enzyme and lysozyme in granulomatous diseases of unknown cause. Ann Intern Med (1981) 0.85
Tryptophan-associated eosinophilic connective-tissue disease. A new clinical entity? JAMA (1990) 0.85
Dyspnea and pulmonary function in the L-tryptophan-associated eosinophilia-myalgia syndrome. Chest (1992) 0.85
Jejuno-ileostomy in the treatment of obesity. Acta Chir Scand (1973) 0.84
In vitro immunoglobulin production by mononuclear cells in rheumatoid arthritis. Clin Immunol Immunopathol (1983) 0.84
Lacrimal gland adenoid cystic carcinoma: intracranial and extracranial en bloc resection. Plast Reconstr Surg (1981) 0.84
Peripheral proliferative retinopathy without oxygen therapy in a full-term infant. Am J Ophthalmol (1980) 0.84
A person is a person and a shpos is not. Man Med (1980) 0.83
Reading in pure alexia. The effect of strategy. Brain (1993) 0.83
The effect of triiodothyronine on 2-deoxy-D-(1-3H)glucose uptake in cultured chick embryo heart cells. Endocrinology (1977) 0.83
Small bowel obstruction as a complication of disseminated varicella-zoster infection. Surgery (1978) 0.82
Achalasia: two effective treatment options--let the patient decide. Am J Gastroenterol (1994) 0.82
Immunosuppressant therapy. Adv Intern Med (1984) 0.82
Technetium pyrophosphate muscle scans in inflammatory muscle disease. Br J Rheumatol (1987) 0.81
Echocardiographic features of cardiac compression by mediastinal pancreatic pseudocyst. Chest (1980) 0.81
Characterization of corticosteroid receptors in natural killer cells: comparison with circulating lymphoid and myeloid cells. Cell Immunol (1985) 0.81
[New method of examination of the salivary glands: the fiberscope]. Inf Dent (1990) 0.81
The Overlap Between Fibromyalgia and Inflammatory Rheumatic Disease: When and Why Does it Occur? J Clin Rheumatol (1995) 0.81
Mechanisms of human cell-mediated cytotoxicity. II. Correction of the selective defect in natural killing in the Chediak-Higashi syndrome with inducers of intracellular cyclic GMP. J Immunol (1982) 0.80